血小板输注已成为现代输血医学的重要内容。肿瘤患者因疾病本身或放化疗等原因易发生血小板减少症,因此临床常通过输注血小板以预防或治疗因血小板质量或数量下降而造成的出血。虽然血小板输注有助于止血,但输注所产生的同种异体免疫会使肿瘤相关并发症的控制变得异常困难。我们就肿瘤患者血小板输注过程中需注意的几个问题做一综述。 Platelet transfusion has become an important part of modern blood transfusion medicine. Patients with cancer due to the disease itself or radiotherapy and chemotherapy and other reasons prone to thrombocytopenia, so often through the clinical infusion of platelets to prevent or treat due to the quality or quantity of platelets caused by bleeding. Although platelet transfusions help to stop bleeding, the allogeneic immunization resulting from infusion can make the control of tumor-related complications exceptionally difficult. We review the several issues that need attention in the platelet transfusion of cancer patients.